Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Semisynthetic ecteinascidins presented in recent patent issued to U. of Illinois

Nov. 3, 1999

Celecoxib in FAP: results of clinical trial discussed at ACG

Nov. 2, 1999

AxyS Pharmaceuticals licenses rights to Signal's SERM-beta compounds for cancer indications

Nov. 2, 1999

Development of antisense-containing regimen for malignant melanoma to be fast-tracked

Oct. 29, 1999

Paracure gets notice of allowance for patent covering modified arglabin compounds

Oct. 29, 1999

CPMP gives favorable opinion on Taxotere for advanced non-small cell lung cancer

Oct. 28, 1999

Additional positive data reported for Cell Pathways' exisulind

Oct. 28, 1999

First macrolide LHRH antagonists patented by Abbott

Oct. 28, 1999

New distamycin derivatives developed at Pharmacia & Upjohn for cancer Rx

Oct. 28, 1999

Dramatic results described for STI-571 in CML patients

Oct. 27, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....